Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region

scientific article (publication date: November 1993)

Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1099/0022-1317-74-11-2391
P8608Fatcat IDrelease_hebeci7byfcexekowwpp6fp3nm
P3181OpenCitations bibliographic resource ID1943695
P698PubMed publication ID8245854
P5875ResearchGate publication ID14953145

P50authorEdward C. HolmesQ28152069
Peter SimmondsQ28379677
P2093author name stringChan SW
Kolberg J
Yap PL
McOmish F
Urdea MS
Irvine B
Cha TA
Beall E
P407language of work or nameEnglishQ1860
P921main subjectvirusQ808
hepatitis CQ154869
Hepatitis C virusQ708693
phylogeneticsQ171184
P304page(s)2391-2399
P577publication date1993-11-01
P1433published inJournal of General VirologyQ6295245
P1476titleClassification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region
P478volume74 ( Pt 11)

Reverse relations

cites work (P2860)
Q42983299A DNA hybridization method for typing hepatitis C virus genotype 2c.
Q25255565A general method for nested RT-PCR amplification and sequencing the complete HCV genotype 1 open reading frame
Q44988872A phase I/II study of recombinant human interleukin-12 in patients with chronic hepatitis C.
Q27469343A phylogenetically conserved stem-loop structure at the 5' border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation.
Q57205742A proposed system for the nomenclature of hepatitis C viral genotypes
Q33855490A retrospective overview of enterovirus infection diagnosis and molecular epidemiology in the public hospitals of Marseille, France (1985-2005).
Q33256564A review of the evidence for the effectiveness of primary prevention interventions for hepatitis C among injecting drug users
Q33997485A serotyping assay for hepatitis C virus in Southeast Asia
Q43001849A shift in the Hepatitis C virus genotype dominance in blood donor samples from Thailand
Q57208129Accumulation of B Lymphocytes with a Naive, Resting Phenotype in a Subset of Hepatitis C Patients
Q27485690Accurate quantification of hepatitis C virus (HCV) RNA from all HCV genotypes by using branched-DNA technology
Q27473009Acute hepatitis C infection after sexual exposure.
Q42999261Alpha-fetoprotein above normal levels as a risk factor for the development of hepatocellular carcinoma in patients infected with hepatitis C virus
Q27469375Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5' untranslated region (5'UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the [...]
Q39154271Amiodarone inhibits the entry and assembly steps of hepatitis C virus life cycle.
Q42983592An in-house method for the detection and quantification of HCV in serum samples using a TaqMan assay real time PCR approach
Q37095842An increased diversity of HCV isolates were characterized among 393 patients with liver disease in China representing six genotypes, 12 subtypes, and two novel genotype 6 variants
Q37719516An overview about hepatitis C: a devastating virus
Q34916120An overview of HCV molecular biology, replication and immune responses
Q43035780Analysis of 5' non-coding region in hepatitis C virus by single-strand conformation polymorphism and low-stringency single specific primer PCR.
Q73629650Analysis of biochemical and virological efficacy of human lymphoblastoid interferon (IFN) in patients with compensated type C liver cirrhosis: comparative study between increase in individual IFN dose and prolonging of treatment period, using a mult
Q27487891Analysis of hepatitis C virus isolates among healthy blood donors and drug addicts in Chiang Mai, Thailand
Q47314419Analysis of naturally occurring resistance-associated variants to NS3/4A protein inhibitors, NS5A protein inhibitors and NS5B polymerase inhibitors in patients with chronic hepatitis C.
Q36679489Analysis of the core and E1 envelope region sequences of a novel variant of hepatitis C virus obtained in Indonesia
Q43041953Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies
Q34545880Antibody production and in vitro behavior of CD27-defined B-cell subsets: persistent hepatitis C virus infection changes the rules.
Q43046988Antiviral treatment of recurrent hepatitis C virus (HCV) infection after liver transplantation: association of a strong, multispecific, and long-lasting CD4+ T cell response with HCV-elimination
Q42996637Apparent epidemic of HCV infection in a haemodialysis unit
Q27469409Assessment of hepatitis C virus sequence complexity by electrophoretic mobilities of both single-and double-stranded DNAs
Q33617717Association between chronic hepatitis C infection and hepatocellular carcinoma in a Scottish population
Q43048778Association of HLA Alleles with Response (Especially Biochemical Response) to Interferon Therapy in Japanese Patients with Chronic Hepatitis C
Q34484305Association of genetic variations in GNB1 with response to peginterferon plus ribavirin therapy for chronic hepatitis C in a Chinese population in Taiwan
Q43046674Association of hepatitis C virus NS5B variants with resistance to new antiviral drugs among untreated patients
Q44654522Association of multispecific CD4(+) response to hepatitis C and severity of recurrence after liver transplantation
Q37313166Avoiding therapeutic pitfalls: the rational use of specifically targeted agents against hepatitis C infection
Q40459443Bioinformatic Analysis of Codon Usage and Phylogenetic Relationships in Different Genotypes of the Hepatitis C Virus.
Q41712075Biological dynamics of viral load in hemodialysis patients with hepatitis C virus
Q33631104Broadly neutralizing antibodies with few somatic mutations and hepatitis C virus clearance
Q27473535CD4+/CD8+ ratio of liver-derived lymphocytes is related to viraemia and not to hepatitis C virus genotypes in chronic hepatitis C
Q45609955CD56(+dim) and CD56(+bright) cell activation and apoptosis in hepatitis C virus infection
Q54231580CD81 Receptor Regions outside the Large Extracellular Loop Determine Hepatitis C Virus Entry into Hepatoma Cells.
Q43037126CD81 expression for discrimination between sustained virologic response and relapse in patients with chronic hepatitis C.
Q34140014Challenge pools of hepatitis C virus genotypes 1-6 prototype strains: replication fitness and pathogenicity in chimpanzees and human liver-chimeric mouse models
Q43032801Change in hepatitis C virus clades: a cross-sectional study of chronic HCV patients in Pakistan from 2000-2010.
Q42980301Changes in hepatitis C virus quasispecies and density populations in patients before and after interferon therapy
Q43040009Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy.
Q35920144Changing pattern of clinical epidemiology on hepatitis C virus infection in southwest china
Q37602315Characterisation of hepatitis C virus genotype among blood donors at the regional blood transfusion centre of Ouagadougou, Burkina Faso
Q35141727Characteristics of HCV co-infection among HIV infected individuals from an area with high risk of blood-borne infections in central China.
Q42987930Characteristics of patients with hepatitis C virus with and without GB virus C/hepatitis G virus co-infection and efficacy of interferon alfa
Q40815800Characterization of an immunologically conserved epitope from hepatitis C virus E2 glycoprotein recognized by HLA-A2 restricted cytotoxic T lymphocytes
Q40831393Characterization of partial NS5B region among hepatitis C virus genotype 6 subtypes isolated from Thai blood donors
Q42986489Cholestatic hepatitis after liver transplantation is associated with persistently high serum hepatitis C virus RNA levels
Q48724304Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome [Science 1989;244:359-362].
Q43047091Chronic hepatitis C in alcoholic patients: prevalence, genotypes, and correlation to liver disease
Q74529990Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis
Q43038265Classification of hepatitis C virus into major types and subtypes based on molecular evolutionary analysis
Q35834810Classification of hepatitis C viruses based on phylogenetic analysis of the envelope 1 and nonstructural 5B regions and identification of five additional subtypes
Q35059546Classifying genotype F of hepatitis B virus into F1 and F2 subtypes
Q39977681Clearance of HCV by Combination Therapy of Pegylated Interferon alpha-2a and Ribavirin Improves Insulin Resistance
Q27473463Clinical Evaluation of Two Methods for Genotyping Hepatitis C Virus Based on Analysis of the 5' Noncoding Region
Q36756371Clinical and epidemiological characteristics of Korean patients with hepatitis C virus genotype 6
Q31054551Clinical and virological characteristics of hepatitis B or C virus co-infection with HIV in Indonesian patients.
Q73114557Clinical features of hepatitis C-infected patients with persistently normal alanine transaminase levels in the Southwestern United States
Q27477946Clinical guidelines on the management of hepatitis C
Q42983646Clinical implications of GBV-C/HGV infection in patients with "HCV-related" chronic hepatitis
Q24514512Clinical significance of hepatitis C virus genotypes
Q36150271Co-infections and transmission networks of HCV, HIV-1 and HPgV among people who inject drugs
Q41841986Coevolution of the hepatitis C virus polyprotein sites in patients on combined pegylated interferon and ribavirin therapy
Q27480736Cold-Temperature Plastic Resin Embedding of Liver for DNA- and RNA-Based Genotyping
Q43048751Comparative analysis of viral titers and histologic features of Pakistani patients infected with hepatitis C virus type 3.
Q35505377Comparative performance evaluation of hepatitis C virus genotyping based on the 5' untranslated region versus partial sequencing of the NS5B region of brazilian patients with chronic hepatitis C.
Q43048799Comparative study of different methods to genotype hepatitis C virus type 6 variants
Q27485751Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients
Q27473038Comparison of Conventional PCR with Real-Time PCR and Branched DNA-Based Assays for Hepatitis C Virus RNA Quantification and Clinical Significance for Genotypes 1 to 5
Q27469399Comparison of DNA enzyme immunoassay and line probe assays (Inno-LiPA HCV I and II) for hepatitis C virus genotyping.
Q36118779Comparison of Three Different Hepatitis C Virus Genotyping Methods: 5'NCR PCR-RFLP, Core Type-Specific PCR, and NS5b Sequencing in a Tertiary Care Hospital in South India.
Q42996047Comparison of envelope 2 CD81 binding regions in PBMC-derived versus serum-derived hepatitis C virus isolates: higher conservation of CD81 region 2 in PBMC isolates
Q37014659Comparison of hepatitis C viral loads in patients with or without coinfection with different genotypes
Q43037312Comparison of line probe assay and DNA sequencing of 5' untranslated region for genotyping hepatitis C virus: description of novel line probe patterns
Q43034268Comparison of real-time quantitative polymerase chain reaction with three other assays for quantitation of hepatitis C virus.
Q43034846Comparison of three HCV genotyping assays: a serological method as a reliable and inexpensive alternative to PCR based assays
Q27486386Complete genome of a European hepatitis C virus subtype 1g isolate: phylogenetic and genetic analyses
Q27485775Concordance of hepatitis C virus typing methods based on restriction fragment length polymorphism analysis in 5' noncoding region and NS4 serotyping, but not in core PCR or a line probe assay
Q27861119Consensus proposals for a unified system of nomenclature of hepatitis C virus genotypes
Q38529929Construction of hepatitis C-SIN virus recombinants with replicative dependency on hepatitis C virus serine protease activity
Q34552781Control of heterologous hepatitis C virus infection in chimpanzees is associated with the quality of vaccine-induced peripheral T-helper immune response
Q34604806Controversies in and challenges to our understanding of hepatitis C.
Q38467109Core as a novel viral target for hepatitis C drugs
Q64954537Core encoding sequences of Hepatitis C virus in Ghanaian blood donors are predominantly mosaics of different genotype 2 strains and cannot distinguish subtypes
Q30757296Correlation between mutations in the interferon sensitivity-determining region of NS5A protein and viral load of hepatitis C virus subtypes 1b, 1c, and 2a
Q42986317Correlation between relative number of circulating low-density hepatitis C virus particles and disease activity in patients with chronic hepatitis C.
Q42989115Correlation between virus genotype and chronicity rate in acute hepatitis C.
Q37142229Critical issues in the treatment of hepatitis C virus infection in methadone maintenance patients
Q33826033Cross reactive cellular immune response to HCV genotype 1 and 4 antigens among genotype 4 exposed subjects
Q33811619Cryoglobulinemia
Q74514123Cryoglobulinemia due to chronic viral hepatitis infections is not a major problem in clinical practice
Q42990339Cryoglobulins and cryoglobulinemia. Diagnostic and therapeutic considerations
Q37884087Current drug discovery strategies for treatment of hepatitis C virus infection
Q37201846Cutting the gordian knot-development and biological relevance of hepatitis C virus cell culture systems
Q27469625De novo initiation of RNA synthesis by the RNA-dependent RNA polymerase (NS5B) of hepatitis C virus
Q45738503Decline of hepatitis C virus load in serum during the first 24 h after administration of interferon-beta as a predictor of the efficacy of therapy
Q42990146Degree and distribution of variability in the 5' untranslated, E1, E2/NS1 and NS5 regions of the hepatitis C virus (HCV).
Q36192394Demographic characteristics and intravenous drug use among hepatitis C patients in the Kota Setar district, Kedah, Malaysia
Q42980131Detection and clinical features of hepatitis C virus type 6 infections in blood donors from Hong Kong
Q43037481Detection of HCV core antigen in human serum and plasma with an automated chemiluminescent immunoassay
Q34359266Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury
Q42994592Detection of hepatitis C virus RNA by in situ hybridization in paraformaldehyde fixed biopsies
Q43037677Detection of hepatitis C virus with RNA polymerase chain reaction in fulminant hepatic failure
Q42986936Determination of HCV RNA concentration by direct quantitation of the products from a single RT-PCR.
Q33962062Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test.
Q42998028Development and evaluation of an automated hepatitis C virus NS5B sequence-based subtyping assay
Q27487022Development of Intergenotypic Chimeric Replicons To Determine the Broad-Spectrum Antiviral Activities of Hepatitis C Virus Polymerase Inhibitors
Q39449520Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen.
Q38327430Diagnosis and Management of Hepatitis C Virus Infection
Q60232505Diagnostic and clinical implications of the different genotypes of hepatitis C virus
Q43031516Difference in quasispecies of the hypervariable region 1 of hepatitis C virus between alcoholic and non-alcoholic patients
Q40942638Differential distribution of IL28B.rs12979860 single-nucleotide polymorphism among Egyptian healthcare workers with and without a hepatitis C virus-specific cellular immune response
Q27485767Differential prevalence of hepatitis C virus subtypes in healthy blood donors, patients on maintenance hemodialysis, and patients with hepatocellular carcinoma in Surabaya, Indonesia
Q34321440Direct-acting antiviral agents for hepatitis C virus infection
Q35866972Discovery of a Novel Human Pegivirus in Blood Associated with Hepatitis C Virus Co-Infection
Q42978750Discrepancy of hepatitis C virus genotypes as determined by phylogenetic analysis of partial NS5 and core sequences
Q45751228Distinct genotypes of a nonenveloped DNA virus associated with posttransfusion non-A to G hepatitis (TT virus) in plasma and peripheral blood mononuclear cells
Q42993720Distribution of HCV genotypes among different exposure categories in Brazil
Q42978542Distribution of genotypes and response to alpha-interferon in patients with hepatitis C virus infection in Germany
Q35649742Distribution of hepatitis C virus genotypes in Canada: Results from the LCDC Sentinel Health Unit Surveillance System
Q39529255Distribution of hepatitis C virus genotypes in Chinese patients with chronic hepatitis C: correlation with patients' characteristics and clinical parameters
Q42981820Distribution of hepatitis C virus genotypes in German patients with chronic hepatitis C: correlation with clinical and virological parameters.
Q42982322Distribution of hepatitis C virus genotypes in Slovenia
Q35080005Distribution of hepatitis C virus genotypes in patients infected by different sources and its correlation with clinical and virological parameters: a preliminary study
Q27487893Distribution of viral genotypes in Italy determined by hepatitis C virus typing by DNA immunoassay
Q35010474Distribution pattern of HCV genotypes & its association with viral load.
Q27485762Diverse patterns of recognition of hepatitis C virus core and nonstructural antigens by antibodies present in Egyptian cancer patients and blood donors
Q42995830Diversity of nucleotide sequences in hypervariable region 1 of hepatitis C virus in Japanese patients with chronic hepatitis C of unknown mode of transmission
Q27485656Dynamic analysis of heterogeneous hepatitis C virus populations by direct solid-phase sequencing
Q43000414Early addition of ribavirin to interferon in chronic hepatitis C not responsive to interferon monotherapy
Q43038116Effect of hepatitis C genotype on mother-to-infant transmission of virus.
Q42990180Effect of interferon therapy on hepatitis C virus RNA in whole blood, plasma, and peripheral blood mononuclear cells.
Q43000283Effect of interferon treatment on serum 2',5'-oligoadenylate synthetase levels in hepatitis C-infected patients
Q42986058Effective prediction of outcome of combination therapy with pegylated interferon alpha 2b plus ribavirin in Japanese patients with genotype-1 chronic hepatitis C using early viral kinetics and new indices
Q34294938Effects of immunosuppression and organ transplantation on the natural history and immunopathogenesis of hepatitis C virus infection
Q39640069Efficacy and safety of telaprevir in patients with genotype 1 hepatitis C infection.
Q43037670Efficacy of interferon alfa therapy in chronic hepatitis C patients depends primarily on hepatitis C virus RNA level
Q30448796Enhanced in vitro potency and in vivo immunogenicity of a CTL epitope from hepatitis C virus core protein following amino acid replacement at secondary HLA-A2.1 binding positions
Q56395674Epidemic history of hepatitis C virus genotypes and subtypes in Portugal
Q36112907Epidemic history of hepatitis C virus infection in two remote communities in Nigeria, West Africa
Q27472758Epidemiological dynamics of hepatitis C virus among 747 German individuals: new subtypes on the advance
Q35507630Epidemiological features of patients infected with HCV genotype 4 in Poland: Epidemiology of HCV genotype 4 in Poland
Q77221647Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment
Q42983274Evaluation and comparison of different hepatitis C virus genotyping and serotyping assays
Q27486402Evaluation of Versant Hepatitis C Virus Genotype Assay (LiPA) 2.0
Q27473495Evaluation of a New Serotyping Assay for Detection of Anti-Hepatitis C Virus Type-Specific Antibodies in Serum Samples
Q42998799Evaluation of automated RNA-extraction technology and a qualitative HCV assay for sensitivity and detection of HCV RNA in pool-screening systems
Q43035190Evaluation of complete genome sequences and sequences of individual gene products for the classification of hepatitis C viruses
Q35990080Evaluation of multiplex nested polymerase chain reaction for routine hepatitis C virus genotyping in egyptian patients
Q27486902Evaluation of the TRUGENE HCV 5'NC Genotyping Kit with the New GeneLibrarian Module 3.1.2 for Genotyping of Hepatitis C Virus from Clinical Specimens
Q42982618Evaluation of two simplified methods for genotyping hepatitis C virus
Q42861856Evidence for action of ribavirin through the hepatitis C virus RNA polymerase
Q34242504Evidence for separation of HCV subtype 1a into two distinct clades.
Q27486806Evidence of Recombination in Intrapatient Populations of Hepatitis C Virus
Q42992701Evidence of hepatitis C virus in cervical smears
Q27490444Evidence of recombination in Hepatitis C Virus populations infecting a hemophiliac patient
Q27477594Evidence of recombination in quasispecies populations of a Hepatitis C Virus patient undergoing anti-viral therapy
Q27473437Evidence of structural genomic region recombination in Hepatitis C virus
Q36931081Evidence of subtype-specific antibodies to antigenic epitopes in the NS5 region of hepatitis C virus in the circulation of patients with chronic hepatitis C.
Q33865608Evolutionary relationships among parvoviruses: virus-host coevolution among autonomous primate parvoviruses and links between adeno-associated and avian parvoviruses
Q58701375Evolving Trends in the Hepatitis C Virus Molecular Epidemiology Studies: From the Viral Sequences to the Human Genome
Q33557770Excellent superiority and specificity of COBAS TaqMan HCV assay in an early viral kinetic change during pegylated interferon alpha-2b plus ribavirin treatment
Q33682538Expanding allelic diversity of Helicobacter pylori vacA.
Q24529494Exposure of hepatitis C virus (HCV) RNA-positive recipients to HCV RNA-positive blood donors results in rapid predominance of a single donor strain and exclusion and/or suppression of the recipient strain
Q35937788Expression of transforming growth factor beta-1 in chronic hepatitis and hepatocellular carcinoma associated with hepatitis C virus infection
Q42986748Factors associated with cirrhosis development in chronic hepatitis C patients from an area of low prevalence
Q43039602Fatal hepatitis C virus infection in a heart transplant recipient detectable by polymerase chain reaction only
Q26822400Finally sofosbuvir: an oral anti-HCV drug with wide performance capability
Q27485996Formation and intracellular localization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia and Sindbis viruses
Q43036009Frequencies of HCV-specific effector CD4+ T cells by flow cytometry: correlation with clinical disease stages
Q35040087Frequency distribution of HCV genotypes among chronic hepatitis C patients of Khyber Pakhtunkhwa
Q27486226Frequency distribution of hepatitis C virus genotypes in different geographical regions of Pakistan and their possible routes of transmission
Q43037218Frequent detection of hepatitis C virus subtype 3a (HCV-3a) isolates in Thailand by PCR using subtype-specific primers
Q42692227Frequent patient-to-patient transmission of hepatitis C virus in a haematology ward
Q42999157Full-genome nucleotide sequence of a hepatitis C virus variant (isolate name VAT96) representing a new subtype within the genotype 2 (arbitrarily 2k).
Q45772528Fulminant hepatitis on withdrawal of chemotherapy in carriers of hepatitis C virus
Q27473215Generation of Infectious Hepatitis C Virus in Immortalized Human Hepatocytes
Q34577134Genetic and biochemical diversity in the HCV NS5B RNA polymerase in the context of interferon α plus ribavirin therapy
Q38479346Genetic and phylogenetic analyses of hantaviral sequences amplified from archival tissues of deer mice (Peromyscus maniculatus nubiterrae) captured in the eastern United States
Q40659243Genetic characterization of ruminant pestiviruses: sequence analysis of viral genotypes isolated from sheep
Q36388411Genetic diversity and evolution of hepatitis C virus in the Latin American region
Q24655361Genetic history of hepatitis C virus in East Asia
Q42982537Genetic variability in the 5' UTR and NS5A regions of hepatitis C virus RNA isolated from non-responding and responding patients with chronic HCV genotype 1 infection
Q42278785Genetic variation in NOS2A is associated with a sustained virological response to peginterferon plus ribavirin therapy for chronic hepatitis C in Taiwanese Chinese
Q36601301Genome sequence of the hepatitis C virus subtype 6n isolated from malaysia.
Q27487540Genome-wide hepatitis C virus amino acid covariance networks can predict response to antiviral therapy in humans
Q27480295Genomic organization of GB viruses A and B: two new members of the Flaviviridae associated with GB agent hepatitis
Q40848400Genotype 3 is the predominant hepatitis C genotype in a multi-ethnic Asian population in Malaysia
Q36826456Genotype analysis of hepatitis C virus among blood donors and inmates in Metro Manila, The Philippines
Q42979026Genotype determination of hepatitis C virus from northern India: identification of a new subtype
Q43037735Genotype distribution and comparison of the putative envelope region of hepatitis C virus from Korean patients
Q43040122Genotype distribution in Nagoya and new genotype (genotype 3a) in Japanese patients with hepatitis C virus
Q43035147Genotypes and virus load in patients with hepatitis C infection
Q43034438Genotypic and epidemiologic characteristics of hepatitis C virus infections among recent injection drug user and nonuser populations
Q27485781Genotypic distribution of hepatitis C virus in different regions of Thailand
Q27485356Genotyping HIV-1 and HCV strains by a combinatorial DNA melting assay (COMA)
Q27485737Genotyping hepatitis C virus isolates from Spain, Brazil, China, and Macau by a simplified PCR method
Q27487882Genotyping of Canadian hepatitis C virus isolates by PCR
Q41439594Genotyping of hepatitis B and C virus Russian isolates for reference serum panel construction
Q27485654Genotyping of hepatitis C virus in South Africa
Q27485754Genotyping of hepatitis C virus isolates from Lebanese hemodialysis patients by reverse transcription-PCR and restriction fragment length polymorphism analysis of 5' noncoding region
Q42983530Genotyping of hepatitis C virus performed by type-specific PCR in comparison to nucleotide sequencing of NS5 and core regions
Q27472740Genotyping of hepatitis C virus types 1, 2, 3, and 4 by a one-step LightCycler method using three different pairs of hybridization probes
Q27487786Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey
Q36461735Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability
Q27485672Greater diversity of hepatitis C virus genotypes found in Hong Kong than in mainland China
Q39355216HBV and HCV chronic hepatitis and cirrhosis.
Q37664059HCV drug discovery aimed at viral eradication
Q34117848HCV genotype distribution and possible transmission risks in Lahore, Pakistan.
Q39457679HCV genotypes among 1013 Saudi nationals: a multicenter study
Q38903085HCV genotypes in Morocco
Q42991121HCV genotypes in Northern Italy: a survey of 1368 histologically proven chronic hepatitis C patients.
Q43930193HCV prevalence and co-infection with HIV among pregnant women in Saint Camille Medical Centre, Ouagadougou
Q43048742HCV serotypes in Brazilian patients
Q42978743HCV transmission in family members of subjects with HCV related chronic liver disease
Q56001841HEPATITIS C
Q27478341HLA class I-restricted cytotoxic T lymphocytes specific for hepatitis C virus. Identification of multiple epitopes and characterization of patterns of cytokine release
Q42981045Hepatic Fas antigen expression before and after interferon therapy in patients with chronic hepatitis C.
Q34103218Hepatic STAT1-nuclear translocation and interleukin 28B polymorphisms predict treatment outcomes in hepatitis C virus genotype 1-infected patients
Q42984394Hepatic lymphoid aggregates in chronic hepatitis C and mixed cryoglobulinemia
Q27490447Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
Q27490450Hepatitis C Virus (HCV) Infection May Elicit Neutralizing Antibodies Targeting Epitopes Conserved in All Viral Genotypes
Q27486013Hepatitis C Virus Diversity and Evolution in the Full Open-Reading Frame during Antiviral Therapy
Q27477554Hepatitis C Virus Down-Regulates Insulin Receptor Substrates 1 and 2 through Up-Regulation of Suppressor of Cytokine Signaling 3
Q37663438Hepatitis C Virus in mainland China with an emphasis on genotype and subtype distribution
Q26775815Hepatitis C genotype 4: The past, present, and future
Q37073708Hepatitis C genotype 4: What we know and what we don't yet know.
Q42981870Hepatitis C genotypes in Finland determined by RFLP.
Q42985109Hepatitis C genotypes in liver transplant recipients: distribution and 1-year follow-up
Q27469411Hepatitis C in a hemodialysis unit: molecular evidence for nosocomial transmission
Q35076885Hepatitis C patient-derived glycoproteins exhibit marked differences in susceptibility to serum neutralizing antibodies: genetic subtype defines antigenic but not neutralization serotype.
Q40560378Hepatitis C updated
Q37420620Hepatitis C virus (HCV) core antigen assay to detect ongoing HCV infection in thai injection drug users
Q27487926Hepatitis C virus (HCV) core serotypes in chronic HCV infection
Q43040543Hepatitis C virus (HCV) genotype distribution in German isolates: studies on the sequence variability in the E2 and NS5 region
Q34215894Hepatitis C virus (HCV) genotype, tissue HCV antigens, hepatocellular expression of HLA-A,B,C, and intercellular adhesion-1 molecules. Clues to pathogenesis of hepatocellular damage and response to interferon treatment in patients with chronic hepat
Q27477979Hepatitis C virus (HCV) genotypes in 373 Italian children with HCV infection: changing distribution and correlation with clinical features and outcome
Q42986448Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma
Q36240052Hepatitis C virus (HCV) genotypes in the Caribbean island of Martinique: evidence for a large radiation of HCV-2 and for a recent introduction from Europe of HCV-4
Q27485684Hepatitis C virus (HCV) subtype prevalence in Chiang Mai, Thailand, and identification of novel subtypes of HCV major type 6
Q27486009Hepatitis C virus NS3 serine proteinase: trans-cleavage requirements and processing kinetics
Q42132899Hepatitis C virus RNA: molecular switches mediated by long-range RNA-RNA interactions?
Q42978470Hepatitis C virus amino acid sequence diversity correlates with the outcome of combined interferon/ribavirin therapy in Chinese patients with chronic hepatitis C.
Q27482007Hepatitis C virus and lymphoma
Q57295205Hepatitis C virus cell culture models: an encomium on basic research paving the road to therapy development
Q42988954Hepatitis C virus dynamics in vivo: effect of ribavirin and interferon alfa on viral turnover
Q36797841Hepatitis C virus genetic variability in patients undergoing antiviral therapy
Q42239862Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma.
Q34503772Hepatitis C virus genotype 3a with phylogenetically distinct origin is circulating in Pakistan.
Q27024231Hepatitis C virus genotype 6: virology, epidemiology, genetic variation and clinical implication
Q27491345Hepatitis C virus genotype frequency in Isfahan province of Iran: a descriptive cross-sectional study
Q42992110Hepatitis C virus genotypes among patients with lichen planus in the Kingdom of Saudi Arabia
Q42989326Hepatitis C virus genotypes and clinical features in hepatitis C virus-related mixed cryoglobulinemia
Q42980056Hepatitis C virus genotypes and subtypes in patients with hepatitis C, with and without cryoglobulinemia
Q34522014Hepatitis C virus genotypes circulating in district Swat of Khyber Pakhtoonkhaw, Pakistan
Q42221723Hepatitis C virus genotypes circulating in patients with chronic hepatitis C in Thailand and their responses to combined PEG-IFN and RBV therapy
Q27488500Hepatitis C virus genotypes distribution and transmission risk factors in Luxembourg from 1991 to 2006
Q43049282Hepatitis C virus genotypes in Hungarian and Austrian patients with chronic hepatitis C.
Q35938587Hepatitis C virus genotypes in Korea and their relationship to clinical outcome in type C chronic liver diseases
Q42979081Hepatitis C virus genotypes in blood donors and patients with chronic hepatitis C.
Q41698449Hepatitis C virus genotypes in chronic hepatitis C patients and in first time blood donors in northeastern Bosnia and Herzegovina
Q41958799Hepatitis C virus genotypes in liver transplant recipients: impact on posttransplant recurrence, infections, response to interferon-alpha therapy and outcome
Q42985123Hepatitis C virus genotypes, hepatitis, and hepatitis C virus recurrence after liver transplantation
Q43031825Hepatitis C virus genotypes: distribution and clinical significance in patients with cirrhosis type C seen at tertiary referral centres in Europe
Q27472749Hepatitis C virus genotyping: interrogation of the 5' untranslated region cannot accurately distinguish genotypes 1a and 1b
Q27472594Hepatitis C virus heteroduplex tracking assay for genotype determination reveals diverging genotype 2 isolates in Italian hemodialysis patients
Q43037861Hepatitis C virus infection among Brazilian hemophiliacs: a virological, clinical and epidemiological study.
Q27490176Hepatitis C virus infection among drug injectors in St Petersburg, Russia: social and molecular epidemiology of an endemic infection
Q41398433Hepatitis C virus infection in dialysis and renal transplantation
Q42994116Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological report
Q27469600Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding
Q26853500Hepatitis C virus molecular evolution: transmission, disease progression and antiviral therapy
Q27472905Hepatitis C virus nonstructural 5A protein and interferon resistance: a new model for testing the reliability of mutational analyses
Q27486393Hepatitis C virus prevalence and genetic diversity among pregnant women in Gabon, central Africa
Q24517933Hepatitis C virus serotype-specific core and NS4 antibodies in injecting drug users participating in the Amsterdam cohort studies
Q42981262Hepatitis C virus subtype 3b infection in a hospital in Japan: epidemiological study
Q42270437Hepatitis C virus subtyping based on sequencing of the C/E1 and NS5B genomic regions in comparison to a commercially available line probe assay.
Q42988066Hepatitis C virus transmission dynamics in injection drug users
Q42989745Hepatitis C virus transmission in hemodialysis units: importance of infection control practices and aseptic technique.
Q35891292Hepatitis C virus variants from Vietnam are classifiable into the seventh, eighth, and ninth major genetic groups
Q43036833Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy
Q27480276Hepatitis C virus-encoded NS2-3 protease: cleavage-site mutagenesis and requirements for bimolecular cleavage
Q34422738Hepatitis C virus. The importance of viral heterogeneity.
Q43036094Hepatitis C virus: From epidemiology and molecular virology to immunobiology
Q24676346Hepatitis C-Z: recent advances
Q71702111Hepatitis C: diagnosis and treatment
Q42978532Hepatitis C: increasing knowledge and unresolved questions
Q36642065Hepatitis C: progress and problems
Q42987616Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors
Q43040414Hepatitis G virus genotypes in a tertiary care centre in southern India
Q42980940Hepatitis G virus infection in hemodialysis patients.
Q42979853Hepatitis GBV-C sequences in patients infected with HCV contaminated anti-D immunoglobulin and among i.v. drug users in Germany.
Q36981344Hepatitis c virus genotype 4 replication in the hepatocellular carcinoma cell line HepG2/C3A.
Q45889715Hepatitis in haemophilia
Q38543225Hepatitis viruses exploitation of host DNA methyltransferases functions
Q39537853Hepatocellular carcinoma in Sweden: its association with viral hepatitis, especially with hepatitis C viral genotypes
Q41157467Heterogeneity of hepatitis C virus
Q43040016High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV.
Q44224943High prevalence of genotype 1 in individuals with hepatitis C in Belo Horizonte, MG
Q42990073High prevalence of hepatitis C virus genotype 6 among certain risk groups in Hong Kong
Q43046878High rate of hepatitis C virus infection and predominance of genotype 4 among elderly inhabitants of a remote village of the rain forest of South Cameroon
Q43047392High rate of long-term virological response after a 1-year course of interferon +/- ribavirin in chronic hepatitis C relapsers. Results of a 191 patients randomized trial
Q40685050High-resolution phylogenetic analysis of hepatitis C virus adaptation and its relationship to disease progression
Q46478778History of viral hepatitis: a tale of dogmas and misinterpretations
Q27481388Human combinatorial libraries yield rare antibodies that broadly neutralize hepatitis C virus
Q36255746Identification of HCV genotypes in HCV infected blood donors
Q27477460Identification of a Naturally Occurring Recombinant Genotype 2/6 Hepatitis C Virus
Q39829773Identification of hepatitis C virus subtype 2c by sequencing analysis in patients from Córdoba, Argentina
Q42990039Identification of in vivo interaction between Hepatitis C Virus core protein and 5' and 3' UTR RNA.
Q42995338Immune selection and genetic sequence variation in core and envelope regions of hepatitis C virus.
Q45750923Immunodominant B-cell domains of hepatitis C virus envelope proteins E1 and E2 identified during early and late time points of infection
Q59200582Immunopathogenesis of hepatitis C virus infection
Q34005309Immunopathogenesis of viral hepatitis
Q37929753Impact of HCV genetic differences on pathobiology of disease.
Q26801381Impact of IL28B, ITPA and PNPLA3 genetic variants on therapeutic outcome and progression of hepatitis C virus infection
Q42988876Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma.
Q42979845Impact of various handling and storage conditions on quantitative detection of hepatitis C virus RNA.
Q39037138Impacts and shortcomings of genetic clustering methods for infectious disease outbreaks.
Q38193551Importance of HCV genotype 1 subtypes for drug resistance and response to therapy
Q36826804Important factors in reliable determination of hepatitis C virus genotype by use of the 5' untranslated region
Q42994314Improved correlation between multiple mutations within the NS5A region and virological response in European patients chronically infected with hepatitis C virus type 1b undergoing combination therapy
Q37263558In vitro characterization of GSK2485852, a novel hepatitis C virus polymerase inhibitor
Q40181090In vitro infection of immortalized primary hepatocytes by HCV genotype 4a and inhibition of virus replication by cyclosporin
Q42827965In vivo assay for hepatitis C viral serine protease activity using a secreted protein
Q34870944In-vitro model systems to study Hepatitis C Virus
Q43031115Increased levels of gammaGT suggest the presence of bile duct lesions in patients with chronic hepatitis C: absence of influence of HCV genotype, HCV-RNA serum levels, and HGV infection on this histological damage
Q35358973Increases in intrahepatic CD68 positive cells, MAC387 positive cells, and proinflammatory cytokines (particularly interleukin 18) in chronic hepatitis C infection
Q42287334Independent factors associated with altered plasma active ghrelin levels in HCV-infected patients
Q42382462Individualized treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Q34970209Infection frequency of hepatitis C virus and IL28B haplotypes in Papua New Guinea, Fiji, and Kiribati
Q42982611Infection with GB virus C and hepatitis C virus in hemodialysis patients and blood donors in Beijing
Q42982624Infection with GB virus C/hepatitis G virus in Brazilian hemodialysis and hepatitis patients and asymptomatic individuals
Q42992334Infection with an unenveloped DNA virus (TTV) in patients with acute or chronic liver disease of unknown etiology and in those positive for hepatitis C virus RNA.
Q43033729Influence of HCV genotype 1 subtypes on the virus response to PEG interferon alpha-2a plus ribavirin therapy
Q39141504Influence of IFNL3.rs12979860 and IFNL4.ss469415590 polymorphism on clearance of hepatitis C virus infection among Egyptians
Q22010973Influence of MHC class II genotype on outcome of infection with hepatitis C virus. The HENCORE group. Hepatitis C European Network for Cooperative Research
Q42993794Inquiries on intraspousal transmission of hepatitis C virus: benefits and limitations of genome sequencing and phylogenetic analysis
Q34333821Insights into the epidemiology, natural history and pathogenesis of hepatitis C virus infection from studies of infected donors and blood product recipients
Q24290542Interaction between complement receptor gC1qR and hepatitis C virus core protein inhibits T-lymphocyte proliferation
Q33788496Interferon alpha plus ribavirin combination treatment of Japanese chronic hepatitis C patients with HCV genotype 2: a project of the Kyushu University Liver Disease Study Group
Q40961282Interferon-alpha-2a. A review of its pharmacological properties and therapeutic use in the management of viral hepatitis
Q38870287Interferon-induced Parkinsonism in a patient with chronic hepatitis C.
Q42997948Interleukin 10 treatment reduces fibrosis in patients with chronic hepatitis C: a pilot trial of interferon nonresponders
Q42990093Interleukin 12 enhances deficient HCV-antigen-induced Th1-type immune response of peripheral blood mononuclear cells
Q58607034Interleukin 28A.rs12980602 and interleukin 28B.rs8103142 genotypes could be protective against HCV infection among Egyptians
Q38856008Interleukin 28B.rs12979860 genotype does not affect hepatitis C viral load in Egyptians with genotype 4 chronic infection
Q45733855Intra-familial transmission of hepatitis B virus in Italy: phylogenetic sequence analysis and amino-acid variation of the core gene
Q72615665Intrafamilial transmission of hepatitis C virus
Q41809253Introduction of an automated system for the diagnosis and quantification of hepatitis B and hepatitis C viruses
Q27486577Investigation of Putative Multisubtype Hepatitis C Virus Infections In Vivo by Heteroduplex Mobility Analysis of Core/Envelope Subgenomes
Q71867881Irish Society of Gastroenterology winter meeting. Dublin, November 1994. Abstracts
Q29619752Isolation of novel virus-like sequences associated with human hepatitis
Q30307173Issues in HIV/Hepatitis C Co-infection
Q47336884Keeping Pace with the Red Queen: Identifying the Genetic Basis of Susceptibility to Infectious Disease.
Q24648164Kinetic and structural analyses of hepatitis C virus polyprotein processing
Q41904514Lack of classic histology should not prevent diagnosis of necrolytic acral erythema
Q42980799Lack of correlation between hepatitis C virus genotypes and clinical course of hepatitis C virus-related cirrhosis
Q35275932Lipid metabolism and HCV infection
Q42988688Liver biopsy is a useful predictor of response to interferon therapy in chronic hepatitis C.
Q42999955Liver-derived hepatitis C virus (HCV)-specific CD4(+) T cells recognize multiple HCV epitopes and produce interferon gamma
Q73562590Long-term efficacy of interferon-alpha and ursodeoxycholic acid in treatment of chronic type C hepatitis
Q42991587Long-term lymphoblastoid interferon-alpha therapy for non-cirrhotic chronic hepatitis C: an Italian multicentre study on dose and duration of IFN alpha treatment.
Q42984513Loss of circulating hepatitis C virus in children who developed a persistent carrier state after mother-to-baby transmission
Q37066393Low-Dose Pegylated Interferon α-2b Plus Ribavirin for Elderly and/or Cirrhotic Patients with Genotype 2 Hepatitis C Virus
Q27005739Medicinal plants against hepatitis C virus
Q33539199Methods for the differentiation of microorganisms.
Q28545051MicroRNAs as predictor markers for response to interferon treatment of chronic hepatitis C genotype-4 in Egyptian patients
Q42681703Molecular analysis of intraspousal transmission of hepatitis C virus
Q35660841Molecular and contextual markers of hepatitis C virus and drug abuse.
Q35755597Molecular biology and clinical implication of hepatitis C virus
Q42999755Molecular characterisation of HCV genotype 4 isolates circulating in Italy
Q40061350Molecular characterization and epidemic history of hepatitis C virus using core sequences of isolates from Central Province, Saudi Arabia.
Q35992896Molecular characterization of Hepatitis C virus 3a in Peshawar
Q43033034Molecular characterization of hepatitis C virus genotype 2a from the entire sequences of four isolates
Q34114168Molecular epidemiology of Hepatitis C virus genotypes in Khyber Pakhtoonkhaw of Pakistan
Q42996451Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis
Q43039877Molecular epidemiology of an outbreak of infection with hepatitis C virus in recipients of anti-D immunoglobulin
Q42987165Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region
Q39384230Molecular heterogeneity and new subtypes of HCV genotype 4.
Q36192689Molecular methods of hepatitis C genotyping.
Q42998892Molecular tracing of the global hepatitis C virus epidemic predicts regional patterns of hepatocellular carcinoma mortality
Q33992691Molecular typing of enteroviruses: current status and future requirements. The European Union Concerted Action on Virus Meningitis and Encephalitis
Q71811848Monokine production by peripheral whole blood in chronic hepatitis C patients treated with interferon
Q45768345Mother-to-infant transmission of hepatitis C virus: a prospective study
Q45748378Mother-to-infant transmission of hepatitis C virus: molecular evidence of superinfection by homologous virus in children
Q27469589Multigene tracking of hepatitis C virus quasispecies after liver transplantation: correlation of genetic diversification in the envelope region with asymptomatic or mild disease patterns
Q40637025Mutations in the NS5A gene predict response to interferon therapy in Japanese patients with chronic hepatitis C and cirrhosis
Q21245104NS4A protein as a marker of HCV history suggests that different HCV genotypes originally evolved from genotype 1b
Q36414090NS5A sequence heterogeneity of hepatitis C virus genotype 4a predicts clinical outcome of pegylated-interferon-ribavirin therapy in Egyptian patients
Q73411285National Scientific Medical Meeting. 11-12 April 1997. Abstracts
Q42989273Natural history of hepatitis C in thalassemia major: a long-term prospective study
Q27469708Natural variation in translational activities of the 5' nontranslated RNAs of hepatitis C virus genotypes 1a and 1b: evidence for a long-range RNA-RNA interaction outside of the internal ribosomal entry site
Q33972205Nested restriction site-specific PCR to detect and type hepatitis C virus (HCV): a rapid method to distinguish HCV subtype 1b from other genotypes
Q38044680Neurological complications of hepatitis C infection
Q27478380New Natural Intergenotypic (2/5) Recombinant of Hepatitis C Virus
Q24654270New hepatitis C virus (HCV) genotyping system that allows for identification of HCV genotypes 1a, 1b, 2a, 2b, 3a, 3b, 4, 5a, and 6a
Q28201488New hepatitis viruses: contenders and pretenders
Q42982178New insights into hepatitis C virus infection in the tribal-dominant part of Northeast India
Q35903826Next Generation Sequencing-Based Investigation of Potential Patient-to-Patient Hepatitis C Virus Transmission during Hemodialytic Treatment
Q42985458Non-isotopic detection of hepatitis C virus quasispecies by single strand conformation polymorphism
Q37032551Nonresponse to treatment for hepatitis C: current management strategies
Q73235078Nosocomial transmission of hepatitis C virus
Q43049546Nosocomial transmission of hepatitis C virus associated with the use of multidose saline vials
Q33592762Novel assay using total hepatitis C virus (HCV) core antigen quantification for diagnosis of HCV infection in dialysis patients
Q29620681Novel insights into hepatitis C virus replication and persistence
Q42980888Nucleotide sequences of the hepatitis C virus core region in patients without anti-core antibody
Q27480288Occurrence of antibodies reactive with more than one variant of the putative envelope glycoprotein (gp70) hypervariable region 1 in viremic hepatitis C virus-infected patients
Q34896257Occurrence of genetic modifications in core, 5'UTR and NS5b of HCV associated with viral response to treatment
Q34701350On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome.
Q36346527Outbreak of hepatitis C virus infection associated with narcotics diversion by an hepatitis C virus-infected surgical technician
Q42993989Outcome of liver transplantation in hepatitis C virus-infected patients who received hepatitis C virus-infected grafts
Q27485669Partial nucleotide sequencing of six subtype 2c hepatitis C viruses detected in Italy
Q73429730Pathomorphological Characteristics and Pathogenesis of Viral Hepatitis
Q27478466Patients with chronic hepatitis C have circulating cytotoxic T cells which recognize hepatitis C virus-encoded peptides binding to HLA-A2.1 molecules
Q27485117Patr-A and B, the orthologues of HLA-A and B, present hepatitis C virus epitopes to CD8+ cytotoxic T cells from two chronically infected chimpanzees
Q42987689Pattern of HCV antibodies with special reference to NS5A reactivity in HCV-infected patients: relation to viral genotype, cryoglobulinemia and response to interferon
Q34134994Pegaferon in hepatitis C: Results of a Multicenter Study
Q34298265Performance comparison of the versant HCV genotype 2.0 assay (LiPA) and the abbott realtime HCV genotype II assay for detecting hepatitis C virus genotype 6.
Q34499902Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant
Q43000568Pharmacodynamics of PEG-IFN alpha differentiate HIV/HCV coinfected sustained virological responders from nonresponders
Q42979944Phylogenetic analysis of hepatitis C virus isolates and their correlation to viremia, liver function tests, and histology
Q38974347Phylogenetic analysis of hepatitis C virus isolates from Tunisian patients
Q42977195Phylogenetic analysis of hepatitis C virus isolates from hemodialysis patients
Q39464752Phylogenetic characterization of genotype 4 hepatitis C virus isolates from Argentina
Q34172845Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa
Q39018381Population dynamics of hepatitis C virus subtypes in injecting drug users on methadone maintenance treatment in China associated with economic and health reform
Q41907539Preclinical characterization of GSK2336805, a novel inhibitor of hepatitis C virus replication that selects for resistance in NS5A
Q34330704Prediction of Sustained Virological Response to Telaprevir-Based Triple Therapy Using Viral Response within 2 Weeks.
Q33959591Prediction of a null response to pegylated interferon α-2b plus ribavirin in patients with high viral load genotype 1b hepatitis C
Q45351981Prediction of efficacy to pegylated interferon-α-2b plus ribavirin in patients with genotype 2 hepatitis C virus using viral response within 2 weeks
Q43037304Prediction of efficient virological response to pegylated interferon/ribavirin combination therapy by NS5A sequences of hepatitis C virus and anti-NS5A antibodies in pre-treatment sera
Q42996606Prediction of relapse or sustained response in biochemical responders by serum hepatitis C virus RNA monitoring during interferon therapy
Q42993278Prediction of successful outcome in a randomised controlled trial of the long-term efficacy of interferon alpha treatment for chronic hepatitis C.
Q42979085Predominance of hepatitis C virus genotype 1b in Bulgaria
Q27481007Pretreatment Sequence Diversity Differences in the Full-Length Hepatitis C Virus Open Reading Frame Correlate with Early Response to Therapy
Q44329316Prevalence and determinants of anti-HCV seropositivity and of HCV genotype among intravenous drug users in Berlin
Q42991384Prevalence and genotype of hepatitis C virus infection in pregnant women and blood donors in Ghana
Q42608699Prevalence and risk factors for HBV, HCV and HDV infections among injecting drug users from Rio de Janeiro, Brazil
Q42252312Prevalence of IL-28B and ITPA genotypes in Chinese Han population infected persistently with hepatitis C virus genotype 6 or HCV-1.
Q43001719Prevalence of hepatitis C virus (HCV) genotypes among positive UAE patients
Q42999911Prevalence of hepatitis C virus (HCV) infection and HCV genotypes of hemodialysis patients in Salvador, Northeastern Brazil
Q42979809Prevalence of hepatitis C virus and distribution of its genotypes in Northern Eurasia.
Q42981745Prevalence of hepatitis C virus genotypes in southern Italy.
Q28583333Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis
Q42997576Prevalence of hepatitis C virus infection and HCV genotypes among hemophiliacs in the State of Bahia, Northeastern Brazil: analysis of serological and virological parameters
Q42994014Prevalence of intrinsic disorder in the hepatitis C virus ARFP/Core+1/S protein
Q42994181Prevalence of mixed infection by different hepatitis C virus genotypes in patients with hepatitis C virus-related chronic liver disease
Q27485927Processing in the hepatitis C virus E2-NS2 region: identification of p7 and two distinct E2-specific products with different C termini
Q45732133Proposed criteria for classification of new genotypes of mumps virus
Q31134123Proposed update to the taxonomy of the genera Hepacivirus and Pegivirus within the Flaviviridae family
Q42987785Prospective virological follow-up of hepatitis C infection in a haemodialysis unit
Q42987319Quantification of the initial decline of serum hepatitis C virus RNA and response to interferon alfa
Q42984115Quantitative detection of hepatitis C virus RNA in the serum of patients with chronic hepatitis C treated with interferon: a pilot study.
Q42982502Quantitative liver parameters of HCV infection: relation to HCV genotypes, viremia and response to interferon treatment
Q43674750Quantitative testing of liver function in relation to fibrosis in patients with chronic hepatitis B and C.
Q42981289Rapid and sensitive genotyping of hepatitis C virus by single-strand conformation polymorphism.
Q42990465Rapid genotyping of hepatitis C virus by direct cycle sequencing of PCR-amplified cDNAs and capillary electrophoresis analysis
Q43036942Real-time RT-PCR for quantitation of hepatitis C virus RNA.
Q37954260Recombination in hepatitis C virus
Q42988498Relation between reactivity to the NS-4 region peptides of hepatitis C virus (HCV) and clinical features among patients infected with HCV genotype 1b.
Q42980957Relationship between viral genotype and viral load in patients with chronic hepatitis C.
Q24814157Replicative homeostasis II: influence of polymerase fidelity on RNA virus quasispecies biology: implications for immune recognition, viral autoimmunity and other "virus receptor" diseases
Q24798257Replicative homeostasis: a fundamental mechanism mediating selective viral replication and escape mutation
Q40620065Rescue of infectious classical swine fever and foot-and-mouth disease virus by RNA transfection and virus detection by RT-PCR after extended storage of samples in Trizol
Q37352979Retracted: Genetic diversity in hepatitis C virus (HCV): A brief review
Q42980410Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study
Q34780196Risk factors and genotypes of hepatitis C virus infection in libyan patients
Q82481674Risk factors for hepatitis B and C in multi-transfused patients in Uruguay
Q33496785Risks and benefits of interferon-alpha in the treatment of hepatitis
Q36246785Roles of ITPA and IL28B genotypes in chronic hepatitis C patients treated with peginterferon plus ribavirin
Q42989444Route of infection, liver histology and response to interferon in patients with chronic hepatitis caused by genotype 4 HCV infection in a Western country
Q42982316Routes of transmission of hepatitis C virus in an endemic rural area of Japan. Molecular epidemiologic study of hepatitis C virus infection
Q34113837Routine serologic testing for hepatitis C virus infection should be instituted among dialysis patients
Q27472939Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication
Q27477965Second infection with a different hepatitis C virus genotype in a intravenous drug user during interferon therapy
Q43037280Selection of more pathogenic hepatitis C virus genotype II during long-term follow-up of interferon-treated patients
Q24564165Sequence analysis of the core gene of 14 hepatitis C virus genotypes
Q43041866Sequence variability in the env-coding region of hepatitis C virus isolated from patients infected during a single source outbreak
Q42981110Sequence variation of the hypervariable region in HCV carriers with normal ALT levels: a comparison with symptomatic carriers
Q27480858Sequence variation within a nonstructural region of the hepatitis G virus genome
Q37040485Sequencing Analysis of NS3/4A, NS5A, and NS5B Genes from Patients Infected with Hepatitis C Virus Genotypes 5 and 6.
Q27477682Serendipitous identification of natural intergenotypic recombinants of hepatitis C in Ireland
Q30732505Serological detection of hepatitis B virus genotypes by ELISA with monoclonal antibodies to type-specific epitopes in the preS2-region product
Q27485780Serological determination of hepatitis C virus genotype: comparison with a standardized genotyping assay
Q33961998Serological determination of hepatitis C virus subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay.
Q42988886Serological differentiation between HCV subtypes 1a and 1b by a recombinant immunoblot assay
Q42984289Serotyping and genotyping of hepatitis C virus (HCV) strains in chronic HCV infection. Commission Hepatologie du CREGG. Club de Reflexion des Cabinets de Groupes en GastroEnterologie
Q42999785Serotyping and genotyping of hepatitis C virus in Taiwanese patients with type C chronic liver disease and uraemic patients on maintenance haemodialysis
Q43033875Serum HCV RNA levels correlate with histological liver damage and concur with steatosis in progression of chronic hepatitis C.
Q35662485Serum Wisteria Floribunda Agglutinin-Positive Mac-2 Binding Protein Values Predict the Development of Hepatocellular Carcinoma among Patients with Chronic Hepatitis C after Sustained Virological Response.
Q71711461Sexual transmission of hepatitis C virus infection
Q42991917Should patients with early loss of serum HCV-RNA during alpha interferon therapy for chronic hepatitis C be treated for 6 or 12 months?
Q33853210Simeprevir-Based Triple Therapy with Reduced Doses of Pegylated Interferon α-2a Plus Ribavirin for Interferon Ineligible Patients with Genotype 1b Hepatitis C Virus
Q39455091Simplified hepatitis C virus genotyping by heteroduplex mobility analysis
Q30421625Small molecule inhibitors of the hepatitis C virus-encoded NS5A protein
Q39760409Specific detection of hepatitis C virus minus strand RNA in hematopoietic cells
Q41302293Specific inhibition of hepatitis C viral gene expression by antisense phosphorothioate oligodeoxynucleotides
Q43001848Standardized hepatitis C virus RNA panels for nucleic acid testing assays
Q30361273Structure and functions of hepatitis C virus proteins: 15 years after.
Q43000686Study of a novel hypervariable region in hepatitis C virus (HCV) E2 envelope glycoprotein
Q41926938Study of the hepatitis C virus in the republic of macedonia
Q27485647Study on reliability of commercially available hepatitis C virus antibody tests
Q27478443Substrate determinants for cleavage in cis and in trans by the hepatitis C virus NS3 proteinase
Q27485771Subtype 2c of hepatitis C virus is highly prevalent in Italy and is heterogeneous in the NS5A region
Q27487935Subtype analysis of hepatitis C virus in Indonesia on the basis of NS5b region sequences
Q40627310Subtype distribution of hepatitis C virus in Jiangsu, China
Q43047003Successful HCV genotyping of previously failed and low viral load specimens using an HCV RNA qualitative assay based on transcription-mediated amplification in conjunction with the line probe assay
Q42980565Superinfection by homotypic virus in hepatitis C virus carriers: studies on patients with post-transfusion hepatitis
Q27485682Survey of type 6 group variants of hepatitis C virus in Southeast Asia by using a core-based genotyping assay
Q30329370Susceptibility testing. Viral pathogens.
Q45422073Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee
Q39673107Synthesis, activity, and pharmacokinetic properties of a series of conformationally-restricted thiourea analogs as novel hepatitis C virus inhibitors
Q42988999Systemic manifestations and liver disease in patients with chronic hepatitis C and type II or III mixed cryoglobulinaemia.
Q92391332Taming a beast: lessons from the domestication of hepatitis C virus
Q27485658Tear fluid of hepatitis C virus carriers could be infectious
Q43041192Testing of blood donations for hepatitis C virus
Q27489040The Evolution of the Major Hepatitis C Genotypes Correlates with Clinical Response to Interferon Therapy
Q35698428The Influence of Hepatitis C Virus Genetic Region on Phylogenetic Clustering Analysis
Q36169070The Phylogeographic and Spatiotemporal Spread of HCV in Pakistani Population
Q35843443The Polymerase Chain Reaction: Essential for the Development of Curative Therapy for Hepatitis C
Q42989109The burden of anti-HCV genotye-4 positivity in renal transplant recipients: 8 years follow-up.
Q36892181The epidemiology of hepatitis C infection in the United States
Q37276135The first complete genome sequence of HCV-1a from Pakistan and a phylogenetic analysis with complete genomes from the rest of the world
Q28654353The global epidemiology of hepatocellular carcinoma: present and future
Q27480848The hepatitis C virus NS4A protein: interactions with the NS4B and NS5A proteins
Q35122636The hepatitis C virus persistence: how to evade the immune system?
Q34709019The impact of polymorphisms in STAT6 on treatment outcome in HCV infected Taiwanese Chinese
Q42223133The intrinsic disorder status of the human hepatitis C virus proteome
Q34210660The molecular biology of hepatitis C virus. Genotypes and quasispecies
Q42993584The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a.
Q73590296The prevalence of HCV infection in a cohort of pregnant women, the related risk factors and the possibility of vertical transmission
Q42985942The prevalence of hepatitis C virus types in patients of the same geographic area, according to the source of infection and liver disease
Q41574241The quasispecies of hepatitis C virus and the host immune response
Q35937739The relationship between virological characteristics of hepatitis C virus (HCV) and reactivity to the regional specific proteins of HCV
Q27470086Towards a solution for hepatitis C virus hypervariability: mimotopes of the hypervariable region 1 can induce antibodies cross-reacting with a large number of viral variants
Q27480747Tracking hepatitis C virus quasispecies major and minor variants in symptomatic and asymptomatic liver transplant recipients
Q43040602Transcription-mediated amplification linked to line probe assay as a routine tool for HCV typing in clinical laboratories
Q41462997Transmission of hepatitis C virus associated with surgical procedures - New Jersey 2010 and Wisconsin 2011.
Q24800686Transmission of human hepatitis C virus from patients in secondary cells for long term culture
Q34991688Transmission of viral hepatitis by kidney transplantation: donor evaluation and transplant policies (Part 2: hepatitis C virus).
Q42984463Trends in HCV prevalence, risk factors and distribution of viral genotypes in injecting drug users: findings from two cross-sectional studies.
Q27485998Two hepatitis C virus glycoprotein E2 products with different C termini
Q42982643Understanding the structural and energetic basis of inhibitor and substrate bound to the full-length NS3/4A: insights from molecular dynamics simulation, binding free energy calculation and network analysis
Q34163394Update on different aspects of HCV variability: focus on NS5B polymerase
Q38584271Update on the Development of Anti-Viral Agents Against Hepatitis C.
Q35960876Use and interpretation of HCV diagnostic tests in the clinical setting
Q27472773Use of a commercially available line probe assay for genotyping of hepatitis C virus 5a strains
Q27480326Use of recombinant protein to identify a motif-negative human cytotoxic T-cell epitope presented by HLA-A2 in the hepatitis C virus NS3 region
Q39192032Usefulness and limitation of phylogenetic analysis for hepatitis C virus core region: application to isolates from Egyptian and Yemeni patients
Q43049593Vaccination against hepatitis C virus infection: miles to go before we sleep
Q29615899Vaccination of chimpanzees against infection by the hepatitis C virus
Q40397337Variability of hepatitis C virus
Q36027172Variability of the preC/C region of hepatitis B virus genotype A from a South African cohort predominantly infected with HIV.
Q43038843Variant analysis and immunogenicity prediction of envelope gene of HCV strains from China
Q27478062Viral Determinants of Resistance to Treatment in Patients with Hepatitis C
Q34549186Viral hepatitis a to e in South mediterranean countries
Q33809445Viral heterogeneity of the hepatitis C virus
Q71804793Virology of hepatitis C virus
Q36034899What you need to know about GB virus C.
Q42982882cDNA sequencing of the 5' noncoding region (5' NCR) to determine hepatitis C genotypes in patients with chronic hepatitis C.

Search more.